Delayed neutralizing antibody response in the acute phase correlates with severe progression of COVID-19

Adaptive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dynamics remain largely unknown. The neutralizing antibody (NAb) levels in patients with coronavirus disease 2019 (COVID-19) are helpful for understanding the pathology. Using SARS-CoV-2 pseudotyped virus, serum sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawasuji, Hitoshi, Morinaga, Yoshitomo, Tani, Hideki, Kimura, Miyuki, Yamada, Hiroshi, Yoshida, Yoshihiro, Takegoshi, Yusuke, Kaneda, Makito, Murai, Yushi, Kimoto, Kou, Ueno, Akitoshi, Miyajima, Yuki, Kawago, Koyomi, Fukui, Yasutaka, Sakamaki, Ippei, Yamamoto, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368204/
https://www.ncbi.nlm.nih.gov/pubmed/34400739
http://dx.doi.org/10.1038/s41598-021-96143-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368204/
https://www.ncbi.nlm.nih.gov/pubmed/34400739
http://dx.doi.org/10.1038/s41598-021-96143-8

Ejemplares similares